Champions Oncology (CSBR) EPS (Basic) Growth (3y) (2014 - 2026)
Powered by 
Analysis
Champions Oncology (CSBR) EPS (Basic) Growth (3y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.67 Bn | 40.59 Bn | 1.44 Bn | -3.09% |
| 2 | Medpace Holdings | 16.45 Bn | 15.95 Bn | 201.64 Mn | 29.15% |
| 3 | Charles River Laboratories International | 13.09 Bn | 12.89 Bn | 452.07 Mn | -26.17% |
| 4 | Icon | 12.79 Bn | 11.86 Bn | 479.29 Mn | -6.13% |
| 5 | Fortrea Holdings | 1.61 Bn | 1.44 Bn | 139.20 Mn | -40.99% |
| 6 | Evotec SE | 625.08 Mn | 199.20 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 420.38 Mn | 335.84 Mn | 18.44 Mn | 40.58% |
| 8 | Champions Oncology | 72.62 Mn | 72.62 Mn | 7.03 Mn | 36.59% |
| 9 | MindWalk Holdings | 60.06 Mn | 51.79 Mn | 1.82 Mn | 38.73% |
| 10 | VivoSim Labs | 1.52 Mn | 1.52 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 36.59% |
| Jan 31, 2026 | 51.84% |
| Oct 31, 2025 | 154.74% |
| Jul 31, 2025 | -12.73% |
| Apr 30, 2025 | -72.73% |
| Jan 31, 2025 | 77.88% |
| Oct 31, 2024 | 37.44% |
| Jul 31, 2024 | 111.98% |
| Apr 30, 2024 | 46.04% |
| Jan 31, 2024 | -66.25% |
| Oct 31, 2023 | -1,161.30% |
| Jul 31, 2023 | -224.72% |
| Apr 30, 2023 | -1.14% |
| Jan 31, 2023 | -93.05% |
| Oct 31, 2022 | -26.93% |
| Jul 31, 2022 | 24.66% |
| Apr 30, 2022 | -5.32% |
| Jan 31, 2022 | 56.30% |
| Oct 31, 2021 | -4.49% |
| Jul 31, 2021 | -31.87% |